L. Frenkel

Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine.

W. Borkowsky, L. Mofenson, S. Spector, 2001, The Journal of infectious diseases.

CD4+ cell count and risk for antiretroviral drug resistance among women using peripartum nevirapine for perinatal HIV prevention

B. Chi, J. Stringer, N. Chintu, 2011, BJOG : an international journal of obstetrics and gynaecology.

Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 Collaborators.

W. Borkowsky, L. Mofenson, S. Spector, 2000, The Journal of infectious diseases.

Antibody response to herpes simplex virus glycoproteins gB and gD

D. Bernstein, Y. Bryson, D. Bernstein, 1990, Journal of medical virology.

Immunization by exposure to live virus (SIVmne/HIV-2287) during antiretroviral drug prophylaxis reduces risk of subsequent viral challenge

D. Montefiori, C.-c. Tsai, L. Frenkel, 2020, bioRxiv.

A prospective study of the effects of acyclovir treatment on the HSV-2 lymphoproliferative response of persons with frequently recurring HSV-2 genital infections.

Y. Bryson, M. Dillon, E. Pineda, 1989, The Journal of infectious diseases.

COVID-19 vaccine hesitancy and anti-vaxxers - supporting healthcare workers to navigate the unvaccinated: Reflections from clinical practice.

L. Frenkel, M. Mendelson, J. Hoare, 2021, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.